Diagnosed prevalence of Alzheimer's disease and related dementias in Medicare Advantage plans
Year: 2020
Type: article
Study design: Observational Study
Abstract: INTRODUCTION: One-third of Medicare beneficiaries are enrolled in Medicare Advantage (MA). Yet, little is known about MA beneficiaries diagnosed with Alzheimer's disease (AD) and AD-related dementias (AD/ADRD). METHODS: We calculated the prevalence of AD/ADRD diagnoses in 2014 and 2016 in three MA plans. We determined the demographic characteristics of beneficiaries diagnosed with AD/ADRD, and whether they disenrolled from the MA plan for any reason within 364 days from the index date. RESULTS: In 2014 and 2016, the overall prevalence of AD/ADRD diagnoses was 5.6% and 6.5%, respectively. In 2016, AD/ADRD beneficiaries were on average 82.4 (SD = 7.4) years of age, 61.8% female, and had multiple comorbidities. By 364 days post-index date, 32% of beneficiaries with AD/ADRD had disenrolled from their plan. The demographic characteristics of 2014 beneficiaries with diagnosed AD/ADRD were similar to their 2016 counterparts. DISCUSSION: The prevalence of AD/ADRD diagnosis in MA is lower than rates reported in Medicare fee-for-service.
DOI: 10.1002/dad2.12048
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,200
Awards: G247302349, Microsimulation Modeling to Compare the Effectiveness and Cost-Effectiveness of Nondrug Interventions to Manage Clinical Symptoms in Racially/Ethnically Diverse Persons with Dementia, G5199840425, G5365733108, G7249921848, Informal Resources of Persons Living with Alzheimer's Disease and Related Dementias: Impact on Hospitalizations, Potentially Avoidable Hopsitalizations and Nursing Home Admissions, Midcareer Mentoring Award for Patient-Oriented Research in Aging, NIA AD/ADRD Health Care Systems Research Collaboratory, NIH Health Care Systems Research Collaboratory-Coordinating Center (U24)
OpenAlex ID: W3039682456
